Fig. 3From: PfHRP2 detection using plasmonic optrodes: performance analysisa Sensorgram for the biofunctionalization in MUA, NHS/EDC, HRP2 antibodies, and casein blocking (shifts of the SPR-dip wavelength). b Mean ± sd of the SPR wavelength shift obtained inside antibodies and blocking, after 90 and 30 min, respectively (n = 6)Back to article page